Antiviral Drugs on the Treatment of SARS-CoV-2
NCT04727775 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2023-08-02
Summary
Retrospective Non-Randomized Analytical Cohort Study of Completed SARS-CoV2 COVID19 Cases
Conditions
- Complication of Medical Care
- Pneumonia, Viral
Interventions
- DRUG
-
Favipiravir
Antiviral drugs
- DRUG
-
Remdesivir
Antiviral drugs
Sponsors & Collaborators
-
Astana Medical University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-01
- Primary Completion
- 2023-07-25
- Completion
- 2023-07-25
Countries
- Kazakhstan
Study Locations
More Related Trials
-
Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease
NCT04344444 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection
NCT05697055 ·Status: UNKNOWN ·Phase: PHASE4
-
Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease
NCT04405999 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19
NCT04358549 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19
NCT04501783 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age
NCT04474457 ·Status: UNKNOWN
-
Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections
NCT04365725 ·Status: COMPLETED
-
Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19
NCT04532931 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus
NCT04344379 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19
NCT04346628 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19
NCT04709835 ·Status: COMPLETED ·Phase: PHASE2
-
Antiviral Agents Against COVID-19 Infection
NCT04468087 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia
NCT04255017 ·Status: UNKNOWN ·Phase: PHASE4
-
Philippine Trial to Determine Efficacy and Safety of Favipiravir for COVID-19
NCT05014373 ·Status: UNKNOWN ·Phase: PHASE3
-
Nitazoxanide Therapy for Patients With COVID-19 Pneumonia
NCT04561219 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Safety of New Oral Antivirals for COVID-19
NCT05894603 ·Status: UNKNOWN
-
A Trial of Remdesivir in Adults With Severe COVID-19
NCT04257656 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19
NCT04730427 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections
NCT03455491 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Safety and Efficacy of Azvudine and Paxlovid in the Treatment of Hospitalized Patients With COVID-19
NCT05996770 ·Status: NOT_YET_RECRUITING
-
A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19
NCT04487574 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Favipiravir Treatment of Patients With COVID-19
NCT04600999 ·Status: COMPLETED ·Phase: PHASE3
-
Real World COVID-19 Antiviral Effectiveness Research
NCT05638919 ·Status: UNKNOWN
-
An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19
NCT04527133 ·Status: UNKNOWN ·Phase: NA
-
A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19
NCT04425460 ·Status: UNKNOWN ·Phase: PHASE3